Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 189(7): 3472-9, 2012 Oct 01.
Article in English | MEDLINE | ID: mdl-22942428

ABSTRACT

Signals through BCR and costimulatory molecules play essential roles in selecting high-affinity B cells with Ig V-region mutations in the germinal centers (GCs) of peripheral lymphoid organs. Lyn-deficient (lyn(-/-)) mice show impaired BCR signal triggering for cell proliferation and GC formation, causing hyper-IgM, and display autoimmunity after aging. In this study, we demonstrate that Lyn-mediated signaling to upregulate GANP is essential for the survival of mature GC-like (mGC) B cells with high-affinity type BCR mutations upon Ag immunization. Transgenic ganp expression into lyn(-/-) mice did not recover the Lyn-deficient phenotype with regard to B cell differentiation, serum Igs, and impaired GC formation in spleens after immunization with nitrophenyl-chicken γ-globulin, but it markedly rescued cell survival of mGC B cells by suppressing DNA damage, thereby increasing the frequency of the Trp(33)-to-Leu mutation in the IgV(H)-186.2 region and affinity maturation of nitrophenyl-binding B cells. GANP may play a critical role in Lyn-mediated signaling for the selection of high-affinity B cells in peripheral lymphoid organs.


Subject(s)
B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/pathology , Germinal Center/immunology , Lymphoid Tissue/immunology , Nuclear Proteins/biosynthesis , Phosphoproteins/biosynthesis , Signal Transduction/immunology , Up-Regulation/immunology , src-Family Kinases/physiology , Animals , B-Lymphocyte Subsets/cytology , Cell Adhesion/genetics , Cell Adhesion/immunology , Cell Survival/immunology , Cells, Cultured , Germinal Center/metabolism , Germinal Center/pathology , Humans , Lymphoid Tissue/metabolism , Lymphoid Tissue/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Nuclear Proteins/genetics , Nuclear Proteins/physiology , Phosphoproteins/genetics , Phosphoproteins/physiology , Signal Transduction/genetics , Up-Regulation/genetics , src-Family Kinases/deficiency , src-Family Kinases/genetics
2.
J Immunol ; 189(3): 1193-201, 2012 Aug 01.
Article in English | MEDLINE | ID: mdl-22753944

ABSTRACT

To investigate signals that control B cell selection, we examined expression of G5PR, a regulatory subunit of the serine/threonine protein phosphatase 2A, which suppresses JNK phosphorylation. G5PR is upregulated in activated B cells, in Ki67-negative centrocytes at germinal centers (GCs), and in purified B220(+)Fas(+)GL7(+) mature GC B cells following Ag immunization. G5PR rescues transformed B cells from BCR-mediated activation-induced cell death by suppression of late-phase JNK activation. In G5PR-transgenic (G5PR(Tg)) mice, G5PR overexpression leads to an augmented generation of GC B cells via an increase in non-Ag-specific B cells and a consequent reduction in the proportion of Ag-specific B cells and high-affinity Ab production after immunization with nitrophenyl-conjugated chicken γ-globulin. G5PR overexpression impaired the affinity-maturation of Ag-specific B cells, presumably by diluting the numbers of high-affinity B cells. However, aged nonimmunized female G5PR(Tg) mice showed an increase in the numbers of peritoneal B-1a cells and the generation of autoantibodies. G5PR overexpression did not affect the proliferation of B-1a and B-2 cells but rescued B-1a cells from activation-induced cell death in vitro. G5PR might play a pivotal role in B cell selection not only for B-2 cells but also for B-1 cells in peripheral lymphoid organs.


Subject(s)
Aging/immunology , Autoimmune Diseases/immunology , B-Lymphocyte Subsets/immunology , Epitopes, B-Lymphocyte/immunology , Germinal Center/immunology , Nuclear Proteins/genetics , Phosphoprotein Phosphatases/genetics , Protein Subunits/genetics , Up-Regulation/immunology , Animals , Autoimmune Diseases/enzymology , Autoimmune Diseases/genetics , B-Lymphocyte Subsets/enzymology , B-Lymphocyte Subsets/pathology , Chickens , Female , Germinal Center/cytology , Mice , Mice, Inbred C57BL , Mice, Inbred NZB , Mice, Transgenic , Nuclear Proteins/biosynthesis , Nuclear Proteins/physiology , Peritoneal Cavity/cytology , Phosphoprotein Phosphatases/biosynthesis , Phosphoprotein Phosphatases/physiology , Protein Subunits/biosynthesis , Protein Subunits/physiology , Rats , Rats, Inbred Lew , Sex Characteristics , Up-Regulation/genetics
3.
Immunobiology ; 217(9): 864-72, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22226668

ABSTRACT

HIV-1 entry into cells is mediated by interactions between the envelope (Env) gp120 and gp41 proteins with CD4 and chemokine receptors via an intermediate called the viral fusion complex (vFC). Here, mAbs were used to find the dynamic changes in expression of antigenic epitopes during vFC formation. A CD4-specific mAb (R275) and anti-vFC mAbs, designated F12-1, F13-6 and F18-4 that recognize the epitopes only appeared by the co-culture of env-transfected 293FT and CD4-transfected 293 cells, were developed by immunizing ganp-gene transgenic mice with an vFC-like structure formed by the same co-culture. The epitopes recognized by the mAbs appeared at different time points during vFC formation: F18-4 appeared first, followed by F13-6, and finally F12-1. The anti-vFC mAbs had little effect on vFC formation or virus neutralization; however, interestingly F12-1 and F18-4 increased exposure of the OKT4-epitope on the domain 3 in the extracellular region of CD4. R275, which recognizes the epitope closely associated with the OKT4-determinant on the domain 3, showed the marked inhibition of vFC formation and viral neutralization activity. The Ab binding to the epitopes appeared during viral membrane fusion might reinforce the appearance of the target epitopes for effective neutralization activity.


Subject(s)
CD4 Antigens/metabolism , Epitopes, T-Lymphocyte/immunology , HIV-1/immunology , Receptors, CXCR4/metabolism , Virus Internalization , env Gene Products, Human Immunodeficiency Virus/immunology , env Gene Products, Human Immunodeficiency Virus/metabolism , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/metabolism , CD4 Antigens/immunology , Cell Line , Epitopes, T-Lymphocyte/metabolism , Gene Order , Gene Targeting , HIV Antibodies/immunology , HIV Antibodies/metabolism , Humans , Immunoglobulin Fc Fragments/immunology , Immunoglobulin Fc Fragments/metabolism , Mice , Mice, Transgenic , Neutralization Tests , Protein Binding , Receptors, CXCR4/immunology , env Gene Products, Human Immunodeficiency Virus/chemistry
4.
J Immunol ; 185(9): 5180-7, 2010 Nov 01.
Article in English | MEDLINE | ID: mdl-20870947

ABSTRACT

The mitotic checkpoint is essential for maintaining genomic stability in differentiating B cells undergoing genetic alterations of the Ig gene. In this study, using real-time RT-PCR and in situ RNA hybridization, we demonstrated that MAD2 mRNA export is selectively regulated by Pcid2/Thp1. Pcid2 small interfering RNA induced a cell-cycle abnormality with increased apoptosis and polyploidy, as previously observed in MAD2-knockdown cells. Pcid2 small interfering RNA reduced MAD2 expression, but not the expression of other cell-cycle checkpoint proteins, such as MAD1 and BUBR1, or the cell-cycle-associated proteins, cyclin A, cyclin B1, and cyclin-dependent kinase 1. In mouse B lineage cells, Pcid2 transcripts appeared in a stage-dependent manner at high levels in bone marrow pre-B and immature B cells, and in spleen transitional 1 and follicular B cells, but at lower levels in pro-B, transitional 2, and marginal zone B cells, suggesting a stage-dependent requirement for MAD2 regulation. Cd19-cre-derived targeting of the Pcid2 gene induced a mature B cell deficiency in mice. These findings indicate that Pcid2 is essential for B cell survival through the regulation of MAD2 expression during B cell differentiation.


Subject(s)
B-Lymphocytes/cytology , Cell Cycle Proteins/metabolism , Gene Expression Regulation/immunology , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cell Cycle/genetics , Cell Cycle/immunology , Cell Cycle Proteins/biosynthesis , Cell Cycle Proteins/genetics , Cell Cycle Proteins/immunology , Cell Differentiation/immunology , Cell Survival/genetics , Cell Survival/immunology , Gene Expression , Immunoblotting , Immunohistochemistry , In Situ Hybridization , Mad2 Proteins , Mice , Mice, Knockout , RNA, Small Interfering , Reverse Transcriptase Polymerase Chain Reaction
5.
Recent Pat DNA Gene Seq ; 3(2): 88-95, 2009.
Article in English | MEDLINE | ID: mdl-19519578

ABSTRACT

The most critical issue for the application of high affinity monoclonal antibodies is their creation. Here, we summarize the cellular and molecular mechanisms by which high affinity antibodies are generated, and then review the attempts of many investigators to create high affinity monoclonal antibodies against various target molecules. High affinity monoclonal antibodies are generated by one or a combination of the following three major methods. (1) The improvement of antibody affinity by introducing mutations in the immunoglobulin V-region genes by in vitro mutagenesis. (2) Screening many clones from a random combinatory repertoire of IgV-region genes using a phage library established in yeast or bacteria. (3) Attempting to introduce many somatic hypermutation of IgV-region genes. We summarize the advantages and applications of each of these methods including recent patents to facilitate informed individual choice. We also extend our review to the current creation of antibodies for HIV research.


Subject(s)
Antibodies, Monoclonal/immunology , Antibody Affinity , HIV Antibodies/immunology , HIV Infections/prevention & control , Animals , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/metabolism , Antibodies, Monoclonal/therapeutic use , HIV Antibodies/genetics , HIV Antibodies/therapeutic use , Humans , Immunoglobulin Variable Region/genetics , Mice , Patents as Topic
6.
Eur J Immunol ; 39(2): 600-11, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19180472

ABSTRACT

Receptor editing is believed to play a critical role in immunological tolerance by altering the specificity of autoreactive B cells that emerge in the bone marrow. To study whether receptor editing is altered in autoimmune disease, recombination activation gene 1 (rag1) transcription in B cells from New Zealand Black (NZB) mice was examined by introducing a GFP gene at the rag1 locus. Female NZB(RAG1-GFP) mice generated autoantibodies and glomerular immune complexes. NZB(RAG1-GFP) mice did not display increased RAG1-GFP signal in B-1 and B-2 cells from the spleen and peritoneal cavity even following in vitro stimulation compared with C57BL/6(RAG1-GFP) control mice. The early B cells in the bone marrow were classified into RAG1-GFP(-) and RAG1-GFP(+) subpopulations. The RAG1-GFP(-) immature B-cell population was in the minority in C57BL/6(RAG1-GFP) mice but was markedly increased in NZB(RAG1-GFP) mice. RAG1-GFP(-) immature B cells from NZB(RAG1-GFP) mice differentiated into anti-dsDNA Ab-producing cells after stimulation by LPS in vitro. RAG1-GFP(-) immature B cells from NZB(RAG1-GFP) mice displayed a different expression profile of transcription factors required for receptor editing, including pax5 and irf4, in comparison with the RAG1-GFP(+) immature B-cell population. In conclusion, the early B-cell subpopulation, which exhibits low RAG1 expression and presumably concomitantly low receptor editing, was found to be increased in NZB mice.


Subject(s)
Homeodomain Proteins/immunology , Precursor Cells, B-Lymphoid/immunology , Animals , Autoantibodies/blood , Autoimmunity/immunology , Female , Gene Knock-In Techniques , Green Fluorescent Proteins/metabolism , Homeodomain Proteins/metabolism , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred NZB , Precursor Cells, B-Lymphoid/drug effects , Precursor Cells, B-Lymphoid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...